To see all protocols that comply with the WHO Essential Medicine List 

This resource provides guidance on how to safely undertake the procedure. Institutional practice may vary in accordance with local policy.

Only health care professionals who have attained competency (as per institutional guidelines) should perform this procedure.

Clinical safety note

There are physical and operational differences between the different types of CADD® pumps. Incorrect programming can lead to over-infusion of medication and has the potential to cause serious injury and death. This protocol is for the CADD-Legacy® Plus pump. This pump is designed for continuous and intermittent infusions of medication in mL/hour.

Only health care professionals who have attained competency as per institutional guidelines in safe administration, handling and waste management of antineoplastic drugs, central venous access device care, and CADD-Legacy® Plus pump management should perform this procedure.

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

29 May 2020